4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-15-086399
Chief Scientific Officer sold 598 shares at $1.26 ($753)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Locke Kenneth W Chief Scientific Officer | 2015-12-17 | Sale | −598 | $1.26 | $753 | 0 | D |
| Open-market sales · 598 sh · avg $1.26 · $753 | |||||||
Loading xslF345X03/doc4.xml…